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Introduction
Bone homeostasis is maintained by the concerted action of 
bone-forming osteoblasts and bone-resorbing osteoclasts. In the 
bone microenvironment, osteoclast differentiation is governed 
by macrophage colony-stimulating factor (M-CSF) and recep-
tor activator of nuclear factor B ligand (RANKL) provided by 
osteoblasts, stromal cells, and lymphocytes (Boyle et al., 2003; 
Walsh et al., 2006). M-CSF ensures the survival of osteoclast 
precursors, and RANKL stimulates signaling pathways required 
for osteoclastogenesis (Boyle et al., 2003; Walsh et al., 2006). 
Upon maturation, osteoclasts tightly seal off bone surfaces and 
secrete acids and proteases to digest bone matrices.
The sophisticated control of both extracellular and intra-
cellular Ca2+ concentrations is pivotal to the proper develop-
ment and function of osteoclasts (Lorget et al., 2000; Nowycky 
and Thomas, 2002). During osteoclast differentiation by 
RANKL, cytosolic Ca2+ concentrations show an oscillatory 
pattern (Takayanagi et al., 2002; Asagiri et al., 2005). For the 
initiation of RANKL-dependent Ca2+ oscillation, the activation 
of PLC and the engagement of inositol 1,4,5-triphosphate 
receptor type2 have been suggested to be essential (Kuroda 
et al., 2008; Shinohara et al., 2008; Yoon et al., 2009). RANKL-
induced Ca2+ oscillation triggers calcineurin-dependent dephos-
phorylation and nuclear translocation of nuclear factor of 
The precise regulation of Ca
2+ dynamics is crucial 
for proper differentiation and function of osteo­
clasts. Here we show the involvement of plasma 
membrane Ca2+ ATPase (PMCA) isoforms 1 and 4 in osteo­
clastogenesis. In immature/undifferentiated cells, PMCAs 
inhibited receptor activator of NF­B ligand–induced 
Ca2+ oscillations and osteoclast differentiation in vitro. 
Interestingly, nuclear factor of activated T cell c1 (NFATc1) 
directly stimulated PMCA transcription, whereas the 
PMCA­mediated Ca2+ efflux prevented NFATc1 activa­
tion, forming a negative regulatory loop. PMCA4 also 
had an anti­osteoclastogenic effect by reducing NO, 
which facilitates preosteoclast fusion. In addition to their 
role in immature cells, increased expression of PMCAs in 
mature osteoclasts prevented osteoclast apoptosis both 
in vitro and in vivo. Mice heterozygous for PMCA1 or null 
for PMCA4 showed an osteopenic phenotype with more 
osteoclasts on bone surface. Furthermore, PMCA4 ex­
pression levels correlated with peak bone mass in pre­
menopausal women. Thus, our results suggest that PMCAs 
play important roles for the regulation of bone homeostasis 
in both mice and humans by modulating Ca2+ signaling 
in osteoclasts.
Plasma membrane calcium ATPase regulates  
bone mass by fine-tuning osteoclast differentiation 
and survival
Hyung Joon Kim,1 Vikram Prasad,2 Seok­Won Hyung,3 Zang Hee Lee,1 Sang­Won Lee,3 Aditi Bhargava,4  
David Pearce,5 Youngkyun Lee,6 and Hong­Hee Kim1
1Department of Cell and Developmental Biology, BK21 Program and Dental Research Institute, Seoul National University, Seoul 110-749, Korea
2Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267
3Department of Chemistry, Korea University, Seoul 136-701, Korea
4Department of Surgery and 5Department of Medicine, University of California, San Francisco, San Francisco, CA 94143
6Department of Biochemistry, School of Dentistry, Kyungpook National University, Daegu 700-412, Korea
© 2012 Kim et al. This article is distributed under the terms of an Attribution–Noncommercial–
Share Alike–No Mirror Sites license for the first six months after the publication date (see 
http://www.rupress.org/terms). After six months it is available under a Creative Commons 































Published December 24, 2012
http://jcb.rupress.org/content/suppl/2012/12/19/jcb.201204067.DC1.html 
Supplemental Material can be found at:
JCB • VOLUME 199 • NUMBER 7 • 2012 1146
(Clapham, 2007; Brini, 2009), the mRNA levels of Atp2b1 
(gene encoding PMCA1) and Atp2b4 prominently increased 
during osteoclastogenesis from mouse bone marrow–derived 
macrophages (BMMs), whereas Atp2b2 (PMCA2) and Atp2b3 
(PMCA3) were not detected during the entire course of osteo-
clastogenesis (Fig. 1 C). In contrast, the expression of isoforms 
of Na+/Ca+ exchanger (NCX), a family of Ca2+ transporters 
expressed in mature osteoclasts (Moonga et al., 2002; Li et al., 
2007), either decreased (Slc8a1 [gene encoding NCX1]) or was 
undetectable during osteoclast differentiation (Fig. 1 D). Quan-
titative real-time PCR experiments (Fig. 1 E) and Western blot 
analyses using a pan-PMCA antibody (Fig. 1 F) further corrob-
orated the up-regulation of PMCA at both the mRNA and pro-
tein levels during osteoclastogenesis from BMMs. Confocal 
microscopy studies revealed that PMCA localized to the baso-
lateral membranes of mature osteoclasts cultured on dentin 
slices (Fig. 1 G). Although the question of whether PMCAs are 
also expressed on the apical (resorbing) membranes could not 
be clearly answered by confocal analyses of cells on dentin disc 
because of autofluorescence of dentin, exclusive basolateral 
localization of PMCA was evident in osteoclasts plated on glass 
coverslips (unpublished data).
The transcription factor NFATc1 is a key regulator of 
osteoclastogenesis and its expression is induced by RANKL 
(Takayanagi et al., 2002; Yang and Li, 2007). Notably, we found 
using the wed-based prediction program PROMO that the pro-
moter regions of Atp2b1 and Atp2b4 contain several putative 
NFATc1 binding sites. To test the possibility of involvement 
of NFATc1 in the regulation of PMCA expression, we over-
expressed a constitutive-active form of NFATc1 (NFATc1-CA) 
in BMMs. As shown in Fig. 1 H, NFATc1-CA overexpression was 
sufficient to induce PMCA expression in the absence of RANKL 
stimulation (Fig. 1 H). In addition, chromatin immunoprecipita-
tion (ChIP) experiments revealed that NFATc1 bound to the 
promoter regions of Atp2b1 and Atp2b4 in RANKL-treated 
BMMs (Fig. 1 I). These data indicate that PMCA expression is 
up-regulated during osteoclastogenesis in an NFATc1-dependent 
manner and suggest the possibility that PMCAs extrude Ca2+ 
across the basolateral membrane of osteoclasts.
PMCA deficiency enhances 
osteoclastogenesis
Because the expression of PMCA isoforms significantly increased 
during osteoclastogenesis, their role for osteoclast differentia-
tion was tested by introducing siRNA into mouse BMM osteo-
clast precursors. The isoform-specific knockdown of PMCA1 
and PMCA4 was confirmed by RT-PCR analysis (Fig. 2 A) and 
Western blotting (Fig. 2 B). The PMCA siRNA-transfected 
BMMs were further cultured in the presence of RANKL to 
allow the formation of mature osteoclasts. The knockdown of 
PMCAs remarkably increased the formation of tartrate-resistant 
acid phosphatase (TRAP)–positive multinuclear osteoclasts 
compared with control siRNA-transfected cells (Fig. 2 C, top). 
The increased osteoclastogenesis by PMCA knockdown resulted 
in a significantly enhanced resorption (Fig. 2 C, bottom), indi-
cating the osteoclasts generated were functionally competent. 
activated T cell c1 (NFATc1; Asagiri et al., 2005; Yang and 
Li, 2007). Because the activity of NFATc1 controls the tran-
scription of osteoclastogenic genes (Asagiri et al., 2005; Walsh 
et al., 2006), the molecular mechanisms by which Ca2+ oscilla-
tions are generated and regulated are of great importance in the 
understanding of mechanisms for osteoclast differentiation. 
In addition, mature osteoclasts absorb vast amounts of Ca2+ 
accompanied by organic bone degradation products during 
resorption. Because excessive Ca2+ ions are toxic to osteoclasts, 
osteoclast survival is ensured by the extrusion of Ca2+ into the 
surrounding extracellular space via transcytosis (Salo et al., 
1997) or certain Ca2+ transporters including Na+/Ca2+ exchangers 
(Moonga et al., 2001; Li et al., 2007).
In proteomic and genomic screening experiments, we 
discovered that the expression of plasma membrane Ca2+ ATPase 
(PMCA) isoforms 1 and 4 was dramatically increased during 
the late phase of osteoclast differentiation. PMCA belongs 
to the P-type pump family that maintains intracellular Ca2+  
homeostasis by exporting Ca2+ from the cytoplasm to the extra-
cellular space (Di Leva et al., 2008; Brini, 2009). It was reported 
that PMCA1 knockout is lethal to mice during early embryonic 
development (Okunade et al., 2004). The major observed 
phenotype of PMCA4 knockout mice was male infertility as 
a result of reduced sperm motility (Schuh et al., 2004). Besides 
its role as a Ca2+ pump, PMCA has been suggested to func-
tion as a signaling molecule in recent studies (Buch et al., 
2005; Cartwright et al., 2009). Of particular note, PMCA4 
functionally interacts with nitric oxide synthase (NOS). Over-
expression of PMCA4 dramatically down-regulated NO synthe-
sis in the ambient Ca2+ concentration where NOS operates 
(Schuh et al., 2001).
Here, we report that PMCAs play dual roles in osteoclast 
differentiation and survival by regulating RANKL-induced 
Ca2+ oscillations in preosteoclasts and mediating Ca2+ extru-
sion in mature osteoclasts. Furthermore, PMCA deficiency in-
duced a low bone mass phenotype in mice. In addition, high 
PMCA4 expression levels showed a positive correlation with 
peak bone mass in premenopausal women. These results sug-
gest a novel role for PMCAs in osteoclast development and 
bone homeostasis.
Results
PMCAs are induced by RANKL during 
osteoclastogenesis
In an effort to identify new molecular players associated with 
osteoclastogenesis, we analyzed gene expression changes during 
osteoclast differentiation from human peripheral blood mono-
nuclear cells (PBMCs) using DNA microarrays (Chang et al., 
2008a). Among the genes significantly increased, ATP2B4 
(gene encoding PMCA4 Ca2+ pump) was present (Fig. 1 A). 
Interestingly, in a proteomic study involving cell-surface pro-
tein purification and subsequent liquid chromatography/mass 
spectrometry/mass spectrometry (LC/MS/MS) analyses, the 
protein level of PMCA1 was found to become higher in mouse 
osteoclast precursors upon stimulation with RANKL (Fig. 1 B; 
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of the TRAP gene expression (Fig. 2 G). Similarly, enhanced 
osteoclastogenesis was observed when PMCA was silenced in 
calvariae organ culture experiments (Fig. S1).
PMCAs regulate the Ca2+ oscillation–
NFATc1 axis in preosteoclasts
It has been suggested that RANKL-induced Ca2+ oscillations 
are crucial for the maintenance of cytosolic Ca2+ concentration 
required for osteoclast differentiation (Takayanagi et al., 2002; 
Walsh et al., 2006; Shinohara et al., 2008). Eosin (tetrabromo-
fluorescein) has been suggested as a potent inhibitor of PMCAs 
(IC50 = 1 µM; Gatto and Milanick, 1993; Gatto et al., 1995). 
Treatment of eosin not only strongly enhanced RANKL- 
induced Ca2+ oscillations in preosteoclasts in vitro but also 
augmented the formation of osteoclasts in vivo (Fig. S2). Con-
sistently, the knockdown of PMCA1 or PMCA4 induced robust 
Ca2+ oscillations in preosteoclasts (Fig. 3 A). NFATc1 is a 
Because PMCA knockdown increased osteoclast number and 
size (Fig. 2 C, top), the expression of osteoclast marker genes 
was analyzed by quantitative real-time PCR (Fig. 2 D). The 
knockdown of PMCA1 and PMCA4 significantly augmented 
the induction of fusion marker genes Tm7sf4 (DC-STAMP) and 
Atp6v0d2 (V-ATPase) as well as differentiation marker genes 
Ctsk (cathepsin K) and Acp5 (TRAP) by RANKL stimulation. 
BMMs obtained from Atp2b1+/ (PMCA1-heterozygous) and 
Atp2b4/(PMCA4-null) mice also exhibited significantly 
accelerated osteoclastogenesis in vitro, compared with wild-
type cells (Fig. 2 E). Finally, the in vivo effect of PMCA knock-
down was analyzed after injecting PMCA-targeting siRNA 
oligonucleotides onto mouse calvariae. A microcomputed 
tomography (CT) analysis (Fig. 2 F, top) and TRAP staining 
(Fig. 2 F, bottom) of calvarial bones clearly revealed that bone 
resorption as well as osteoclast formation increased signifi-
cantly in the absence of PMCA, with concomitant up-regulation 
Figure 1. PMCA expression was increased dur-
ing RANKL-induced osteoclast differentiation. 
(A) Human PBMCs were cultured in the presence 
of 30 ng/ml M-CSF and 100 ng/ml RANKL. 
After 3 and 7 d of culture (preosteoclast and 
mature osteoclast stages, respectively), total 
RNAs were extracted and subjected to DNA 
microarray analysis. The relative signal inten-
sity of ATP2B4 (the gene encoding PMCA4) 
mRNA detected in a DNA microarray analy-
sis is shown. Data are means ± SD (**, P < 
0.01). (B) Mouse BMMs were incubated with 
30 ng/ml M-CSF or M-CSF plus 100 ng/ml 
RANKL for 36 h. Biotinylated cell surface pro-
teins were prepared as described in Materi-
als and methods and subjected to LC/MS/MS 
analysis. The elution profile of peptides from 
LC is shown. Arrows indicate PMCA1 peptides 
identified by subsequent mass spectrometry 
analyses. (C and D) Mouse BMMs were stimu-
lated with 100 ng/ml RANKL in the presence 
of 30 ng/ml M-CSF for the indicated times. 
Total RNA was subjected to RT-PCR analysis 
to examine the expression levels of Atp2b and 
Slc8a families (the genes encoding NCXs). 
The mRNA expression in mouse brain was 
used as a positive control. Ctsk (cathepsin K) 
is a marker gene for osteoclast differentiation. 
(E) Quantitative real-time PCR analysis of 
Atp2b1 and Atp2b4 transcripts was performed 
with BMMs treated with 100 ng/ml RANKL 
plus 30 ng/ml M-CSF for the indicated times. 
The mRNA expression levels were normalized 
against those of Hprt1. The error bars show 
the mean ± SD of three independent experi-
ments. (F) Cell lysates from BMMs treated with 
100 ng/ml RANKL plus 30 ng/ml M-CSF for 
the indicated times were subjected to Western 
blotting. The expression levels of total PMCA 
and NFATc1 were examined with pan-PMCA 
and NFATc1 antibodies. (G) PMCA immuno-
staining (Cy3) was performed with mature 
mouse osteoclasts cultured on dentin discs. 
Plasma membrane ganglioside GM1 was co-
stained using FITC-conjugated cholera toxin B. 
Cross-sectional images were reconstructed 
through the z-axis by confocal microscopy 
(A, apical; B, basolateral). Bars, 5 µm. (H) BMMs were infected with viruses harboring empty vector (pMSCV) or constitutively active NFATc1 (pMSCV-
NFATc1-CA). 2 d after infection, PMCA and NFATc1 expression was examined by Western blotting. (I) BMMs were treated with 100 ng/ml RANKL plus 
30 ng/ml M-CSF for 2 d. ChIP was performed using an NFATc1 antobody followed by a PCR amplification of the promoter regions of Atp2b1 or Atp2b4 
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Figure 2. PMCA deficiency enhanced osteoclast differentiation. (A–D) BMMs were transfected with scrambled control siRNA oligonucleotides (Con-si) or 
isoform-specific PMCA1 (P1-si) or PMCA4 (P4-si) siRNA and further cultured in the presence of 100 ng/ml RANKL and 30 ng/ml M-CSF. At 48 h after 
transfection, PMCA mRNA (A) and protein (B) levels were examined. (C) TRAP staining was performed after culturing BMMs with 100 ng/ml RANKL and 
30 ng/ml M-CSF for 3 d (top). Bars, 200 µm. For the examination of resorption activities, BMMs plated on dentin discs were cultured in the presence of 
RANKL plus M-CSF for 5 d. Resorption pits were visualized by a confocal laser scanning of dentin discs (bottom). Bars, 50 µm. OC, osteoclast. (D) The 
mRNA expression of Tm7sf4 (DC-STAMP), Atp6v0d2 (V-ATPase), Ctsk (cathepsin K), and Acp5 (TRAP) was analyzed by quantitative real-time PCR after cul-
turing BMMs in the presence of 100 ng/ml RANKL and 30 ng/ml M-CSF for the indicated times. (E) Atp2b1+/, Atp2b4/, and corresponding wild-type 
BMMs were stimulated with 100 ng/ml RANKL plus 30 ng/ml M-CSF for 3 d and stained for TRAP activity. Bars, 200 µm. (F and G) The in vivo knockdown 
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In this context, we hypothesized that increased PMCA expres-
sion in mature osteoclasts might facilitate the removal of intra-
cellular Ca2+ during bone resorption, preventing Ca2+-induced 
apoptosis. To test this hypothesis, the TUNEL staining was per-
formed with trabecular bone sections of femurs from Atp2b1+/ 
and Atp2b4/ mice. Both PMCA-deficient mice exhibited con-
spicuously more TUNEL-positive osteoclasts compared with 
wild-type mice (Fig. 5, A and B), supporting the notion of an 
anti-apoptotic role for PMCAs in mature osteoclasts. When 
cultured on dentin slices in vitro, osteoclasts derived from 
Atp2b1+/ and Atp2b4/ mice also showed more apoptotic 
nuclei compared with wild-type cells (Fig. 5, C and D). To fur-
ther examine the role of PMCAs in bone-resorbing osteoclasts, 
isolated mature osteoclasts were transfected with PMCA siRNAs 
and cultured on dentin slices. The TUNEL staining of these 
osteoclasts showed a significantly higher number of TUNEL-
positive cells in PMCA-silenced culture (Fig. 5, E and F). In 
addition, PMCA-silencing in osteoclasts promoted the cleavage 
of PARP and caspase-3 upon ionomycin treatment (Fig. 5 G), 
indicating that osteoclasts are more susceptible to Ca2+-induced 
apoptosis in the absence of PMCAs. The increase in apopto-
sis led to a marked reduction in resorbed areas on dentin slices 
when PMCAs were silenced in mature osteoclasts, although 
slightly deeper resorption pits were formed upon the knockdown 
of PMCAs (Fig. 5 H). Similar enhancement of apoptosis by 
PMCA siRNA was also observed when osteoclasts were grown on 
glass slides and challenged with ionomycin to mimic Ca2+ entry 
during bone resorption, whereas the overexpression of PMCAs 
strongly prevented Ca2+-induced apoptosis (Fig. 5, I and J).
PMCA4 but not PMCA1 is involved  
in NO-dependent osteoclast fusion
The knockdown of PMCA4 alone induced comparable accelera-
tion of osteoclast differentiation, despite that the PMCA1 isoform 
was dominantly expressed over PMCA4 in osteoclast precursors 
(Figs. 1 and 2). This result may suggest a possibility of additional 
function of PMCA4 involved in the regulation of osteoclasto-
genesis. Interestingly, PMCA4 was suggested to inhibit NO pro-
duction (Schuh et al., 2001), which is known to promote the 
fusion of preosteoclasts in the late phase of osteoclastogenesis 
(Nilforoushan et al., 2009). As shown in Fig. 6 A, the Ca2+-
dependent neuronal NOS (nNOS) expression was significantly 
increased upon RANKL stimulation of BMMs. Furthermore, 
PMCA4 physically interacted with nNOS in preosteoclasts, 
whereas PMCA1 did not (Fig. 6 B). The knockdown of PMCA4, 
but not that of PMCA1, significantly enhanced NO production in 
preosteoclasts (Fig. 6 C). NOC-12, an NO donor, greatly aug-
mented the size of osteoclasts, supporting the role of NO in pre-
osteoclast fusion (Fig. 6 D). Although both PMCA1 and PMCA4 
siRNA increased the formation of larger osteoclasts, only the 
PMCA4 siRNA-induced development of large osteoclasts was 
Ca2+-dependent key transcription factor for osteoclastogenesis 
(Kim et al., 2005; Sharma et al., 2007). The dephosphorylation 
of NFATc1 by calcineurin followed by nuclear translocation 
and binding to its own promoter up-regulates NFATc1 expres-
sion during osteoclast differentiation through a process called 
auto-amplification (Asagiri et al., 2005). In accordance with the 
increased Ca2+ oscillations, both PMCA1 and PMCA4 siRNA 
significantly increased the number of cells with nuclear NFATc1, 
whereas the addition of a calcineurin inhibitor cyclosporine A 
almost completely abolished NFATc1 nuclear localization 
(Fig. 3, B and C). Western blotting analyses further confirmed 
elevated NFATc1 levels in nuclear fractions of PMCA knock-
down cells (Fig. 3 D). In sharp contrast to the PMCA knock-
down, the overexpression of rat PMCA1 or mouse PMCA4 in 
BMMs (Fig. 3 F) strongly suppressed RANKL-dependent Ca2+ 
oscillations (Fig. 3 E) as well as osteoclastogenesis (Fig. 3, 
E and G). However, the silencing of PMCA1 and PMCA4 did 
not markedly alter other receptor activators of NF-B signaling 
pathways including the phosphorylation of MAPKs, the expres-
sion of c-Jun and c-Fos, or the activation of PLC1 (Fig. S3).
PMCAs regulate bone homeostasis in vivo
To examine the in vivo role of PMCAs in bone homeostasis, 
femurs from Atp2b1+/ (PMCA1-heterozygous) and Atp2b4/ 
(PMCA4-null) mice were analyzed. The von Kossa staining of 
femurs from 6-wk-old male mice revealed a lower amount of 
mineralized bone in both Atp2b1+/ and Atp2b4/ mice com-
pared with respective wild-type mice (Fig. 4 A). Similarly, the 
CT analyses of metaphyseal regions of femurs showed lower 
trabecular bone volume and bone mineral density in both 
PMCA-insufficient mice (Fig. 4 A). Finally, histological assess-
ments confirmed a significant reduction in trabecular bone 
volumes (hematoxylin and eosin staining) and a marked in-
crease in the osteoclast surface (TRAP staining) in Atp2b1+/ 
and Atp2b4/ mice compared with wild-type mice. These ef-
fects of PMCA deficiency on bone homeostasis were osteo-
clast specific because the number of osteoblasts was similar in 
both PMCA-insufficient mice to that of corresponding wild-
type mice (Fig. 4 A). Furthermore, the mineral apposition 
rate was not significantly different in Atp2b1+/ or Atp2b4/ 
mice compared with wild-type mice (Fig. 4 B). In addition, the 
knockdown of PMCA expression or the inhibition of PMCA 
activity in calvarial cells did not affect osteoblast differentiation 
in vitro (Fig. S4).
PMCAs facilitate the survival of  
bone-resorbing mature osteoclasts
Intracellular Ca2+ overload is highly toxic to cells. The disposal 
of surplus intracellular Ca2+ is particularly important in mature 
osteoclasts because massive Ca2+ influx occurs when osteo-
clasts resorb the mineral components of bone (Salo et al., 1997). 
calvariae is shown (top). Bars, 1 mm. Decalcified calvariae tissue sections along the dotted red line were stained for TRAP activity and counterstained with 
toluidine blue (bottom). Bars, 100 µm. The bone volume/tissue volume (BV/TV) and osteoclast surface/bone surface (OC.S/BS) were calculated from CT 
and histomorphometry, respectively. CB denotes calvarial bones. (G) The mRNA levels of Atp2b1, Atp2b4, and Acp5 in calvariae were examined by 
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However, nNOS siRNA dramatically reduced the osteoclasts 
fusion index in PMCA4-silenced osteoclast precursors. These 
data support the role of PMCA4 in regulating NO production and 
osteoclast fusion by inhibiting nNOS activity.
High PMCA4 gene expression correlates 
with high peak bone mass in humans
With ample evidence for PMCA in osteoclast regulation in mice, 
we next sought to investigate the potential association between 
inhibited by the NOS inhibitor L-NMMA (Fig. 6, D and E). To 
further delineate the role of PMCA4 in nNOS-mediated osteo-
clasts fusion, siRNA oligonucleotides targeting nNOS were 
introduced into PMCA-silenced preosteoclasts, which were fur-
ther cultured in the presence of RANKL to allow the formation 
of mature osteoclasts with the confirmation of specific knock-
down by Western blotting (Fig. 6, F and G). The knockdown of 
nNOS only slightly reduced the osteoclast fusion index (Kaneda 
et al., 2000) in control and PMCA1-silenced cells (Fig. 6 H). 
Figure 3. PMCA reduced the RANKL-dependent Ca2+ 
oscillations and subsequent NFATc1 nuclear localiza-
tion in preosteoclasts. (A–C) BMMs on glass cover-
slips were transfected with scrambled control siRNA 
or PMCA siRNA and further incubated for 2 d with 
30 ng/ml M-CSF and 100 ng/ml RANKL. (A) Cells 
were loaded with Fura-2/AM for the recording of 
Ca2+ oscillations (presented as a ratio of maximal fluor-
escence) in individual preosteoclast (BMMs treated 
with RANKL for 2 d). Each colored line represents 
Ca2+ oscillations in a single cell. 10 µM ionomycin 
was added at the end of the experiment (arrow) to 
determine the maximal Ca2+-induced fluorescence. 
(B and C) Cells were stained with NFATc1 antibody (FITC 
labeled) and lamin B antibody (Cy3 labeled) to detect 
the nuclear localization of NFATc1 (arrows). Treatment 
of 1 µM cyclosporineA (CyA) for 3 h induced exclusive 
translocation of NFATc1 to the cytosol (arrowheads). 
Bars, 50 µm. (D) NFATc1 localization was examined 
biochemically by subjecting nuclear fractions from the 
cells treated as in B to Western blotting. (E and F) 
PMCA1 (pcDNA-rPMCA1) or PMCA4 (pMX-PMCA4) 
were overexpressed in BMMs. (E) Ca2+ oscillations 
were monitored in BMMs after RANKL treatment for 
2 d (top). TRAP staining was performed after culturing 
the cells for 4 d (bottom). Bars, 200 µm. (F) PMCA1 
or PMCA4 expression levels were examined by Western 
blotting after culturing the cells for 2 d. (G) The number 
of TRAP-positive multinucleated cells was counted from 
E. Data are means ± SD, representative of more than three 
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Discussion
The precise regulation of Ca2+ dynamics is crucial for proper 
differentiation and function of osteoclasts. RANKL induces 
oscillations of intracellular Ca2+ concentrations that trigger 
NFATc1 activation, which is a prerequisite for osteoclast differ-
entiation. For the initiation of RANKL-dependent Ca2+ oscilla-
tions in osteoclasts, PLC activation is essential (Shinohara 
et al., 2008; Yoon et al., 2009). Furthermore, Kuroda et al., 
(2008) reported that the inositol 1,4,5-triphosphate receptor was 
PMCA gene expression and bone homeostasis in humans. To 
this end, we analyzed a set of publicly available genomics data 
deposited in GEO (accession no. GSE7158) in which DNA 
microarray experiments were performed using blood mono-
cytes obtained from 878 healthy Chinese women aged between 
20 and 45. The microarray results were compared between 
12 subjects with lowest peak bone mass and 14 subjects with 
highest peak bone mass. In this dataset, PMCA4 gene (ATP2B4) 
expression exhibited a significantly higher level in women with 
high peak bone mass (Fig. 7, A and B).
Figure 4. PMCA-deficient mice show an osteopenic 
bone phenotype. (A) Sections of femurs embedded in 
methyl methacrylate from 6-wk-old male Atp2b1+/, 
Atp2b4/, and corresponding wild-type littermate 
mice were subjected to von Kossa/van Geison stain-
ing (top). Bars, 500 µm. After CT analyses, 3D recon-
struction and transaxial images were shown (middle). 
Bars, 1 mm. The hematoxylin/eosin (HE) and TRAP 
staining were performed with tibiae sections embed-
ded in paraffin (bottom). Bars, 200 µm. (B) The min-
eral apposition rate was measured in endocortical 
bones of tibia sections embedded in methyl methac-
rylate after intraperitoneal injection of calcein (green) 
followed by xylenol orange (red). The fluorescence-
labeled margins of cortical bones are indicated by 
arrows. Bars, 50 µm. B, bone; M, marrow space. Data 
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Figure 5. PMCA enhanced the survival of mature osteoclasts. (A and B) In situ TUNEL assay was performed in sections of tibiae embedded in paraffin 
from 6-wk-old male Atp2b1+/, Atp2b4/, and corresponding wild-type littermate mice. (A) Arrows indicate apoptotic osteoclasts on bone surfaces. Bars, 
100 µm. (B) The number of TUNEL-positive osteoclasts per total number of osteoclasts was quantified. Data are means ± SD of the representative experiment 
performed in quintuplicate (n = 5; **, P < 0.01). (C and D) Mature osteoclasts derived from Atp2b1+/, Atp2b4/, and corresponding wild-type BMMs 
were plated on dentin discs. (C) After 2 d of mature osteoclasts culture, apoptotic osteoclasts on dentin discs were evaluated by TUNEL staining (green). 
Nuclei were shown by DAPI staining. Bars, 20 µm. (D) The number of TUNEL-positive nuclei per total number of nuclei was counted. (E and F) Mature osteo-
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In our experiments, the increased expression of PMCAs 
persisted during osteoclastogenesis and reached a maximal 
level in mature osteoclasts (Fig. 1), leading to the hypothesis 
that these Ca2+ pumps might have additional roles in mature 
osteoclasts in addition to their role to diminish Ca2+ oscillations 
in developing osteoclasts. During bone resorption, a large 
amount of Ca2+ released from the bone enters osteoclasts via 
several Ca2+ transporters or channels localized on the apical 
membrane of osteoclasts including a plasma membrane ryano-
dine receptor (Moonga et al., 2002), TRPV5 (van der Eerden 
et al., 2005), and NCX (Li et al., 2007). Because high intracel-
lular Ca2+ can be toxic to osteoclasts, excessive Ca2+ needs to be 
sequestered from the cytosol or expelled into the extracellular 
space. In this context, a continuous discharge of Ca2+ across the 
basolateral membrane has been observed in bone-resorbing 
osteoclasts (Berger et al., 2001). Although a Ca2+-ATPase 
activity was discovered in the purified plasma membranes in 
chicken osteoclasts over two decades ago (Bekker and Gay, 
1990), studies on its identification and function in osteoclasts 
have not been thoroughly performed until the present. Here we 
suggest that PMCAs localized on the basolateral membrane of 
mature osteoclasts (Fig. 1) might operate to extrude superfluous 
intracellular Ca2+ across the basolateral membrane to prevent 
Ca2+-induced apoptosis of osteoclasts. In support of this 
hypothesis, we observed a significantly higher number of apop-
totic osteoclasts in Atp2b1+/ mice and Atp2b4/ mice 
compared with that of wild-type mice (Fig. 5). These results 
were further supported by in vitro experiments in which the 
knockdown of PMCAs resulted in a dramatically enhanced 
apoptosis in osteoclasts either cultured on bone slices or on 
glasses (Fig. 5, E and I). It should be noted that the plasma 
membrane NCX is another candidate considered for the re-
moval of intracellular Ca2+ from osteoclasts. However, we ob-
served that the mRNA expression of Ncx1 (Slc8a1) dramatically 
decreased during osteoclast differentiation, whereas the tran-
scripts of Ncx2 and Ncx3 were not detected during osteoclasto-
genesis (Fig. 1 D). Furthermore, a recent publication by Li 
et al., (2007) predicted that NCX works in an influx mode on 
apical membranes promoting the entry of Ca2+ present in re-
sorption lacunae into bone-resorbing osteoclasts. Combined 
with the reported anti-apoptotic roles of PMCA in HepG2, 
HeLa, mouse smooth muscle cells, and T cells (Chami et al., 
2003; Okunade et al., 2004; Pellegrini and Scorrano, 2007), the 
up-regulation of PMCA expression in bone-resorbing osteo-
clasts might be beneficial in preventing apoptosis by extrud-
ing excessive Ca2+.
critical for RANKL-induced Ca2+ oscillations and osteoclasto-
genesis. However, mechanisms for the termination of Ca2+  
oscillations remain unknown although Ca2+ oscillations gradually 
disappear in the late stages of osteoclastogenesis. In the present 
study, we showed that the expression of two major Ca2+ extru-
sion pumps, PMCA1 and PMCA4, increased dramatically dur-
ing the late stages of osteoclast differentiation (Fig. 1). Notably, 
overexpression of PMCAs in osteoclast precursors dramatically 
diminished the amplitudes of Ca2+ oscillations, reducing the 
osteoclastogenic potential (Fig. 3). In contrast, the knockdown 
of PMCAs resulted in a marked increase in Ca2+ oscillations. 
Consistent with these in vitro data, radiological and histomor-
phometric analyses of Atp2b1+/ and Atp2b4/ mice revealed 
increased osteoclastogenesis with concomitant reduction of 
bone volume without any difference in bone formation (Fig. 4). 
To our knowledge, this study is the first demonstration that the 
plasma membrane Ca2+ pump is directly involved in the regula-
tion of RANKL-induced Ca2+ oscillations and osteoclast differ-
entiation both in vitro and in vivo. Interestingly, the knockdown 
of both PMCA1 and PMCA4 isoforms slightly increased the 
expression SERCA2 and reduced that of TRPV5 (Fig. S5), both 
of which have been shown to regulate cytosolic Ca2+ concentra-
tions in osteoclasts (van der Eerden et al., 2005; Yang et al., 
2009). However, it is highly unlikely that the observed pro- 
osteoclastogenic effects induced by PMCA deficiency were 
mainly caused by the indirect regulation of those proteins be-
cause individual knockdown of PMCA1 or PMCA4 signifi-
cantly increased Ca2+ oscillations and osteoclastogenesis without 
conspicuous alterations in the SERCA2 and TRPV5 expression. 
Nonetheless, detailed dissection on the cross talk between the 
Ca2+ regulators in osteoclasts such as PMCA, SERCA, and 
TRPV is required to fully understand the mechanism by which 
osteoclast Ca2+ oscillations are controlled.
The transcriptional induction of PMCA genes was depen-
dent on NFATc1 activity (Fig. 1). The promoter region of 
Atp2b1 and Atp2b4 contained several putative NFATc1 binding 
sites that indeed associated with NFATc1 (Fig. 1 I). Combined 
with the observation that the NFATc1 nuclear translocation was 
significantly increased in PMCA-silenced cells (Fig. 3 B), it is 
likely that an NFATc1-PMCA negative regulatory loop is oper-
ating to fine-tune osteoclast differentiation. We have reported 
such feedback regulation of NFATc1 by dual specificity tyro-
sine kinase 1A and Nogo-A during osteoclastogenesis (Lee 
et al., 2009, 2012). Thus, these data add another line of evi-
dence that NFATc1 activity is regulated by positive and nega-
tive feedback mechanisms.
on dentin discs were assessed by TUNEL assay (green). Nuclei were visualized by DAPI staining. Bars, 20 µm. (F) The number of TUNEL-positive nuclei 
was quantified. The error bars show the mean ± SD of the representative experiment performed in quintuplicate (**, P < 0.01). (G) Mature osteoclasts 
were transfected with control (Con-si) or isoform-specific siRNAs targeting PMCA1 (P1-si) or PMCA4 (P4-si). After 24-h incubation, cells were treated with 
10 µM ionomycin for 16 h. PARP/caspases-3 cleavage was examined by Western blotting. (H) Dentin discs used in E were observed under confocal laser 
scanning microscope after lysing cells with 0.5% Triton X-100. Both resorbed area and resorption depth were quantified using LSM image browser 4.2 
(Carl Zeiss). Data are means ± SD from the representative of three experiments performed in seven replicates (**, P < 0.01; *, P < 0.05). Bar, 50 µm. 
(I) PMCAs were either knocked down or overexpressed by transfecting BMMs with siRNA oligonucleotides (P1+P4-si) or PMCA overexpression constructs 
(P1-O/E and P4-O/E). After differentiation into mature osteoclasts by RANKL treatment for 4 d, cells were treated with 1 µM ionomycin for 16 h before 
DAPI and TUNEL (green) staining followed by observation under a confocal microscope. As a positive control for apoptosis, etoposide treatment (50 µM, 
16 h) was included. The TUNEL-positive apoptotic nuclei are indicated by arrows. Bars, 50 µm. (J) The percentage of osteoclasts containing more than three 
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coimmunoprecipitated with nNOS (Fig. 6 B), which is in accor-
dance with previous studies that showed a physical interaction 
between PMCA4 and nNOS in smooth muscle cells (Schuh 
et al., 2003) and the inhibition of nNOS by PMCA4 caused by 
a local decrease in Ca2+ concentration (Schuh et al., 2001). The 
importance of PMCA–nNOS interaction in osteoclast fusion 
was clearly demonstrated by the dramatic decrease in the osteo-
clast fusion induced by PMCA4 knockdown in the absence of 
Although both isoforms were expressed in osteoclasts, 
PMCA1 and PMCA4 do not seem to be functionally redundant. 
The siRNA-mediated specific knockdown of either isoform 
of PMCA alone was sufficient to significantly enhance Ca2+  
oscillations and osteoclast differentiation (Figs. 2 and 3). Fur-
thermore, PMCA4 but not PMCA1 was involved in the regu-
lation of NO, which is suggested to enhance osteoclast fusion. 
In RANKL-treated osteoclast precursors, only PMCA4 was 
Figure 6. PMCA4 but not PMCA1 inhibits NO 
generation in osteoclast precursors. (A) BMMs 
were cultured in the presence of 100 ng/ml 
RANKL and 30 ng/ml M-CSF for the indicated 
times. Cell lysates were subjected to Western 
blotting to examine the expression levels of 
nNOS protein. The mouse brain lysates were 
used as positive control. (B) BMMs were in-
cubated for 2 d with 30 ng/ml M-CSF and 
100 ng/ml RANKL. After cell lysis, immuno-
precipitation was performed with an antibody 
against PMCA1 or PMCA4. Immunoprecipi-
tated proteins were detected by anti-nNOS or 
anti-pan-PMCA antibodies. (C) BMMs on glass 
coverslips were transfected with control siRNA 
or isoform-specific PMCA siRNA and further 
incubated with RANKL and M-CSF for 2 d. 
Cells were loaded with an NO indicator dye, 
DAF-2 DA. As a positive control, cells were 
stimulated overnight with 100 ng/ml LPS. As 
a negative control, cells were pretreated with 
NO synthase inhibitor L-NMMA (10 µM) for 2 h, 
and further cultured overnight with 100 ng/ml 
LPS. Bars, 20 µm. (D and E) BMMs were trans-
fected with control siRNA or isoform-specific 
PMCA siRNA and cultured in the presence of 
RANKL and M-CSF for 4 d. The NO donor 
NOC-12 or L-NMMA was included for the 
final 2 d. (D) Cells were stained for TRAP activ-
ity. Bars, 200 µm. (E) The size of osteoclasts 
was measured. (F–H) After culturing control 
and PMCA-silenced BMMs for 2 d with RANKL 
and M-CSF, cells were transfected with control 
or nNOS-siRNA oligonucleotides. Cells were 
further cultured with RANKL and M-CSF for 
3 d. (F) After 5 d of culture, osteoclastogenesis 
was assessed by TRAP staining. Bars, 50 µm. 
(G) The knockdown of PMCA1, PMCA4, and 
nNOS was confirmed by Western blotting. 
(H) The fusion index was calculated from the 
cells in F. All quantitative data are means ± SD, 
representative of three experiments performed 
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Materials and methods
Reagents
Recombinant human soluble RANKL and human M-CSF were purchased 
from PeproTech. Lipofectamine 2000 and Fura-2/AM were purchased 
from Invitrogen. Antibodies against PMCAs were purchased from Santa 
Cruz Biotechnology, Inc. (pan-PMCA) and Thermo Fisher Scientific (PMCA1 
and PMCA4). Phospho-specific antobodies for p38, ERK1/2, JNK, CREB, 
and PLC1 were obtained from Cell Signaling Technology. Antibodies 
against p38, ERK1/2, JNK, c-Jun, PLC1, and cleaved caspases-3 were 
also purchased from Cell Signaling Technology. Antibodies for c-Fos, 
NFATc1, tubulin, PARP, and lamin B were obtained from Santa Cruz 
Biotechnology, Inc. Anti–-actin, FITC-conjugated cholera toxin B subunit, 
ionomycin, eosin Y, the leukocyte acid phosphatase assay kit, and all other 
chemicals were obtained from Sigma-Aldrich.
Animals and in vitro osteoclastogenesis
The mutant PMCA1 (Atp2b1) and PMCA4 (Atp2b4) lines were prepared 
and maintained on the mixed (129Svj and Blackswiss) genetic background 
as previously described (Okunade et al., 2004). Loss of both copies of 
Atp2b1 caused embryonic lethality, but heterozygous mutants had no ob-
servable disease phenotype. Atp2b4/ mutant mice showed no embry-
onic lethality and appeared externally normal. Although Atp2b1+/ mice 
and wild-type littermates were generated by breeding Atp2b1+/ and wild-
type breeder-mates, Atp2b4/ and wild-type littermates were generated 
by crossing Atp2b4+/ mice; genotypes were confirmed by PCR analysis 
using primers previously described (Okunade et al., 2004). All mice were 
maintained and procedures were performed as per guidelines by the 
National Institutes of Health (Guide for the Care and Use of Laboratory 
Animals). Animal experiment protocols were approved by the Committees 
on the Care and Use of Animals in Research at Seoul National University 
and University of Cincinnati. BMMs obtained from 5-wk-old ICR or PMCA 
mutant mice were used as osteoclast precursor cells for in vitro osteoclasto-
genesis experiments as described previously (Lee et al., 2008). In brief, 
mouse whole bone marrow cells, isolated by flushing the marrow space of 
femora and tibiae, were incubated overnight on culture dishes in –modified 
Eagle medium (-MEM) supplemented with 10% FBS. After discarding ad-
herent cells, floating cells were further incubated with M-CSF (30 ng/ml) 
on Petri dishes. BMMs became adherent after a 3-d culture and were used 
as osteoclast precursor cells. Upon incubation of BMMs (3 × 104 cells/well 
in 48-well plates) with 30 ng/ml M-CSF and 100 ng/ml RANKL, >80% of 
nNOS (Fig. 6 H). Thus, our data indicate that PMCA4 has 
a unique role of NO regulation during osteoclastogenesis, in 
addition to the modulation of Ca2+–NFATc1 axis. Notably, the 
expression level of PMCA4 rather than that of PMCA1 exhib-
ited a higher correlation with peak bone mass in women (Fig. 7, 
A and B). The precise underlying mechanisms by which bone 
mass is regulated by PMCAs in humans, including the possible 
involvement of NO, need to be investigated in further studies.
To summarize, we propose dual roles of PMCAs during 
osteoclastogenesis (Fig. 7, C and D). During osteoclast differ-
entiation (Fig. 7 C), NFATc1 increases PMCA expression in a 
RANKL-dependent manner. In late stages of osteoclast differ-
entiation, high levels of PMCA cause efflux of intracellular 
Ca2+, reducing Ca2+ oscillations and limiting NFATc1 activi-
ties. This autoregulatory loop consisting of NFATc1, PMCA, 
and Ca2+ oscillations fine-tunes osteoclastogenesis. An addi-
tional mode of osteoclastogenesis regulation exists in which 
PMCA4 inhibits NO production that expedites osteoclast fusion. 
Therefore, PMCAs may limit excessive osteoclast formation by 
lowering intracellular Ca2+ and NO. In bone-resorbing osteo-
clasts (Fig. 7 D), maximal PMCA expression ensures osteoclast 
survival by the extrusion of excessive Ca2+ across the basolat-
eral membrane in the face of massive Ca2+ entry upon bone 
resorption. An osteopenic bone phenotype was observed in both 
Atp2b1+/ and Atp2b4/ mice, suggesting that in the absence 
of PMCA the advantageous conditions for osteoclast differenti-
ation dominated over adverse effects on osteoclast survival in 
vivo. Because PMCA4 expression correlated with high peak 
bone mass in women, the modulation of PMCA4 expression or 
activity might serve as a novel strategy against bone erosive 
diseases such as osteoporosis.
Figure 7. Elevated ATP2B4 gene expression 
correlates with high peak bone mass in humans. 
(A and B) ATP2B1 and ATP2B4 mRNA ex-
pression levels were analyzed from gene 
expression dataset GSE7158 deposited in GEO. 
The difference in mRNA expression between 
high and low peak bone mass groups was 
analyzed by Mann-Whitney U test (*, P < 
0.05). (C) During the early stage of osteoclast 
differentiation, increased intracellular Ca2+ 
concentrations trigger NFATc1 autoamplifica-
tion and PMCA transcription. In the late stage 
of osteoclast differentiation, increased PMCAs 
expel cytosolic Ca2+, diminishing Ca2+ oscil-
lations and attenuating NFATc1 activation. 
PMCA4 possesses an additional inhibitory role 
in osteoclastogenesis by inhibiting NO pro-
duction in osteoclast precursors. (D) In mature 
bone-resorbing osteoclasts, increased PMCAs 
discharge Ca2+ across basolateral membrane 
in favor of osteoclast survival in the face of 
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ChIP
ChIP assays were performed based on the protocol provided by the manu-
facturer (EZ ChIP kit; EMD Millipore) and the previously published method 
with slight modifications (Ha et al., 2010). In brief, BMMs were cultured 
with 30 ng/ml M-CSF and 100 ng/ml RANKL for 48 h to induce NFATc1 
expression before cross-linking using formaldehyde. After sonication, the 
chromatin was immunoprecipitated with 5 µg each of control IgG antibody 
(Santa Cruz Biotechnology, Inc.) or NFATc1 antibody (Santa Cruz Biotech-
nology, Inc.). The eluted DNA fragments were analyzed by PCR using spe-
cific primers flanking the NFATc1 binding sites located within 1.5 kb 
upstream of Atp2b1 or Atp2b4 transcription initiation sites. Putative NFATc1 
binding sites were identified using the web-based prediction program 
PROMO. Two putative NFATc1 binding sites of Atp2b1 promoter region 
(1,103 to 1,092 and 52 to 44) and four putative NFATc1 binding 
sites of Atp2b4 promoter region (1,292 to 1,283, 1,161 to 1,153, 
1,047 to 1,039, and 51 to 43) were identified. PCR primer 
sequences are listed in Table S2. Input samples were also subjected to PCR 
with the same primers.
Western blotting and Immunoprecipitation
Western blotting and immunoprecipitation experiments were performed 
as previously described (Ryu et al., 2006; Kim et al., 2007). Cells were 
disrupted in lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1.5 mM 
MgCl2, 1 mM EGTA, 1% Triton X-100, 10 mM NaF, 1 mM Na3VO4, and 
complete protease inhibitor cocktail) and 30 or 45 µg of cell lysates were 
resolved by 8–10% SDS-PAGE. Separated proteins were transferred to a 
polyvinylidene difluoride membrane (GE Healthcare) and the membrane 
was blocked with 5% skim milk and probed with appropriate primary anti-
bodies. After 1-h incubation with HRP-conjugated secondary antibodies, 
the immunoreactivity was detected using chemiluminescence. For coimmuno-
precipitation experiments, 1 mg of cell lysates was immunoprecipitated 
with 2 µg of anti-PMCA1 or anti-PMCA4 antibodies and immunoblotted 
using nNOS or pan-PMCA antibodies. Control immunoprecipitation was 
performed using a mouse IgG isotype control antibody. Nuclear fractions 
were prepared by lysing cells in a hypotonic lysis buffer (10 mM Hepes, 
pH 7.9, 1.5 mM MgCl2, 10 mM KCl, and 0.5 mM PMSF) and solubilizing 
nuclear pellets with the sequential addition of 15 µl of high salt buffer 
(20 mM Hepes, pH 7.9, 420 mM NaCl, 25% glycerol, 1.5 mM MgCl2, 
0.2 mM EDTA, 0.5 mM PMSF, and 0.5 mM DTT) and 75 µl of storage buf-
fer (20 mM Hepes, pH 7.9, 100 mM NaCl, 20% glycerol, 0.2 mM EDTA, 
0.5 mM PMSF, and 0.5 mM DTT). Protein concentration was determined 
using a detergent-compatible protein assay kit (Bio-Rad Laboratories).
Confocal microscopy
To detect the NFATc1 localization, preosteoclasts cultured on glass cover-
slips were fixed with 3.7% formaldehyde and permeabilized with 0.1% tri-
ton X-100. After blocking in PBS containing 1% BSA, coverslips were 
incubated with anti-laminB or anti-NFATc1 antibodies diluted (1:50, 1 h) 
in PBS containing 1% BSA for 2 h. Subsequently, cells were washed and 
stained with DAPI or Cy3-conjugated secondary antibodies (1:300, 1 h). 
For the measurement of PMCA localization, osteoclasts cultured on dentin 
discs were fixed and stained with FITC-conjugated cholera toxin (for 
GM1-containing plasma membrane labeling, 2.5 µg/ml, 20 min) plus 
anti–pan-PMCA antibodies. After washing, cells on dentin discs were 
mounted and images were obtained using a confocal microscope 
(FV300; Olympus).
Measurement of intracellular Ca2+ concentrations
BMMs on glass coverslips were cultured with 30 ng/ml M-CSF and 100 ng/ml 
RANKL for 48 h. For the measurement of Ca2+ oscillations in individual 
osteoclast precursor, cells were loaded with 5 µM Fura-2/AM and 0.05% 
pluronic F127 for 40 min at room temperature. After washing three times 
with Hank’s balanced salt solution (Gibco), the fluorescence was recorded 
at every 500 ms with 340/380 nm excitations and 510 nm emission at 
37°C using a digital imaging system (Cascade 650; Photometrics) and 
Metafluor image analysis software (Universal Imaging).
Calcein-xylenol orange double labeling
To evaluate the mineral apposition rate in vivo, Atp2b1+/, Atp2b4/, 
and wild-type littermate mice were sequentially injected with 25 mg/kg 
calcein and 90 mg/kg xylenol orange intraperitoneally with an interval 
of 6 d (Lee et al., 2009). At 3 d after the last injection, mice were killed 
and dissected tibiae were embedded in methyl methacrylate resins. Tissue 
sections were observed under a laser-scanning microscope (LSM5 PASCAL; 
Carl Zeiss).
the total cells became mononuclear TRAP-positive cells (preosteoclasts) 
after 2 d of culture. Fully mature multinucleated osteoclasts were formed 
after further incubation for 1 or 2 d. The osteoclast fusion index was de-
fined as the number of nuclei per one multinucleated osteoclast (Kaneda 
et al., 2000). The exact time required for full differentiation varied slightly 
between experiments, and osteoclastogenesis was generally slower in 
transfected or virus-infected cells. To purify mature osteoclasts, BMMs (107 
cells) were differentiated into osteoclast on collagen gel-coated 10-cm 
culture dishes in the presence of 30 ng/ml M-CSF and 100 ng/ml RANKL. 
Osteoclasts were detached by treating 0.2% collagenase (Invitrogen) 
at 37°C for 10 min, briefly centrifuged, and replated on culture dishes to 
allow reattachment for 1 h at 37°C. After the second round of collagenase 
treatment and gentle pipetting, only firmly attached mature osteoclasts 
remained whereas osteoclast precursors were removed.
Plasmid construction, transfection, and retroviral gene transfer
BMMs were transfected with pcDNA-rPMCA1 constructs (Bhargava et al., 
2002) using Lipofectamin 2000. The entire coding region of mouse 
PMCA4 was PCR amplified from mouse osteoclast cDNA using the forward 
primer 5-GGGCTCGAGCCACCATGACGAATCCACCAGGA-3 and the 
reverse primer 5-GGGGCGGCCGCTCAGACCGGTGTCTCCAG-3. The 
amplified PCR product was cloned into a pMX-IG vector using XhoI and 
NotI sites. Retroviral packaging was performed by transfecting Plat-E cells 
with plasmids using Lipofectamin 2000. At 48 h after transfection, culture 
medium containing viral particles was collected and filtered through 0.45-µm 
syringe filters (Sartorius Stedim Biotech). For retroviral infection, BMMs 
were incubated in the virus-containing medium with 10 µg/ml polybrene 
and 30 ng/ml M-CSF for 24 h. The infection efficiency was >80% when 
measured for GFP fluorescence.
Gene knockdown by siRNA
The siRNA duplexes for PMCA1 (NM_026482_stealth_3610), PMCA4 
(NM_213616_stealth_1507), and the negative universal control (medium 
GC content) were purchased from Invitrogen. Oligonucleotide siRNA 
duplexes were transfected into BMMs with Lipofectamin 2000 according 
to the manufacturer’s protocol.
Gene-expression profiling
The gene profiling of human PBMC-derived osteoclasts was described pre-
viously (Chang et al., 2008a). For osteoclast formation, hPBMCs were cul-
tured in the presence of 30 ng/ml M-CSF and 100 ng/ml RANKL for 
3 (preosteoclast) or 7 d (mature osteoclast). Total RNAs were extracted 
from hPBMCs, reverse transcribed, and transcribed in vitro into biotin- 
labeled cRNAs. These cRNAs were hybridized with the GeneChip Human 
Genome U133 Plus 2.0 Array (Affymetrix). The array chips were scanned 
with a GeneArray scanner (Affymetrix) and were analyzed by Microarray 
Suite 5.0 (Affymetrix). Publicly available gene expression datasets of 
human samples were downloaded from GEO (accession no. GSE7158) 
and the correlation between ATP2B1/ATP2B4 mRNA expression and peak 
bone mass was analyzed.
Cell-surface biotinylation and LC/MS/MS experiments
BMMs (4 × 105 cells/well in 6-well plates) were cultured with 30 ng/ml 
M-CSF alone or 200 ng/ml M-CSF plus RANKL for 36 h. A total of 2 × 107 
cells were surface biotinylated using the Pinpoint cell-surface protein isola-
tion kit (Thermo Fisher Scientific) following the manufacturer’s instructions. 
After cell lysis, biotinylated proteins were purified using a streptavidin 
column and subjected to SDS-PAGE. Protein bands showing differential 
expression were excised, digested with trypsin, and analyzed by nano-
LC/MS/MS (Lee et al., 2008) equipped with an LTQ-FT mass spectrometer 
(Thermo Fisher Scientific) and an 1100 Series NanoLC pump (Agilent Tech-
nologies). Data from the mass spectrometer were analyzed using the Bio-
works 3.2 software (Thermo Fisher Scientific). The search results were 
subsequently evaluated by PeptideProphet and home-built software.
Real-time PCR and RT-PCR analyses
For real-time PCR analysis, 1.5 µg of total RNA was reverse transcribed 
and PCR amplified with SYBR green master mix (Applied Biosystems) for 
40 cycles of 15-s denaturation at 95°C and 1-min amplification at 60°C in 
ABI Prism 7500 System (Applied Biosystems). Relative mRNA expression 
levels were presented by normalizing against Hprt1 mRNA levels. For 
RT-PCR analysis, total RNAs were isolated with TRIzol reagent (Invitrogen) 
and 2 µg of RNAs were reverse transcribed with Superscript II (Invitrogen) 
according to the manufacturer’s instructions. The primer sets used in real-
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Online supplemental material
Fig. S1 shows the effect of PMCA knockdown on osteoclastogenesis in cal-
variae organ culture models. Fig. S2 shows the enhanced RANKL-induced 
Ca2+ oscillations and osteoclast differentiation upon eosin treatment in vitro 
and in vivo. Fig. S3 shows the changes in P38, ERK1/2, JNK1/2, and 
PLC1 phosphorylation as well as c-Fos expression after RANKL stimulation 
in PMCA knocked down cells by Western blotting. Fig. S4 shows no change 
in osteoblast differentiation after PMCA knockdown or inhibition in vitro. 
Fig. S5 shows the expression levels of SERCA2 and TRPV5 in PMCA knocked 
down cells by Western blotting. Table S1 lists primer sets used in real-time 
PCR and RT-PCR experiments. Table S2 shows PCR primer sequences used 
in ChIP experiments. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.201204067/DC1.http://www.jcb.org/ 
cgi/content/full/jcb.201204067/DC1
This work was supported by grants from the Science Research Center 
(20120000490) and the Ministry of Health and Welfare (A111787) to 
H.-H. Kim, and the Korea Research Foundation grants funded by the Korean 
government (KRF-2008-313-E00439 and NRF-2010-359-E00016 to Y. Lee 
and NRF-2010-860-20100096 to H.J. Kim). V. Prasad was supported by 
American Heart Association 11BGIA7720005 and National Institutes of 
Health grant HL061974.
The authors declare no conflict of interest.
Submitted: 13 April 2012
Accepted: 21 November 2012
References
Asagiri, M., K. Sato, T. Usami, S. Ochi, H. Nishina, H. Yoshida, I. Morita, 
E.F. Wagner, T.W. Mak, E. Serfling, and H. Takayanagi. 2005. 
Autoamplification of NFATc1 expression determines its essential role 
in bone homeostasis. J. Exp. Med. 202:1261–1269. http://dx.doi.org/ 
10.1084/jem.20051150
Bekker, P.J., and C.V. Gay. 1990. Biochemical characterization of an elec-
trogenic vacuolar proton pump in purified chicken osteoclast plasma 
membrane vesicles. J. Bone Miner. Res. 5:569–579. http://dx.doi.org/ 
10.1002/jbmr.5650050606
Berger, C.E., H. Rathod, J.I. Gillespie, B.R. Horrocks, and H.K. Datta. 2001. 
Scanning electrochemical microscopy at the surface of bone-resorbing 
osteoclasts: evidence for steady-state disposal and intracellular functional 
compartmentalization of calcium. J. Bone Miner. Res. 16:2092–2102. 
http://dx.doi.org/10.1359/jbmr.2001.16.11.2092
Bhargava, A., R.S. Mathias, J.A. McCormick, M.F. Dallman, and D. Pearce. 
2002. Glucocorticoids prolong Ca(2+) transients in hippocampal-derived 
H19-7 neurons by repressing the plasma membrane Ca(2+)-ATPase-1. 
Mol. Endocrinol. 16:1629–1637. http://dx.doi.org/10.1210/me.16.7.1629
Boyle, W.J., W.S. Simonet, and D.L. Lacey. 2003. Osteoclast differentiation and 
activation. Nature. 423:337–342. http://dx.doi.org/10.1038/nature01658
Brini, M. 2009. Plasma membrane Ca(2+)-ATPase: from a housekeeping function 
to a versatile signaling role. Pflugers Arch. 457:657–664. http://dx.doi.org/ 
10.1007/s00424-008-0505-6
Buch, M.H., A. Pickard, A. Rodriguez, S. Gillies, A.H. Maass, M. Emerson, 
E.J. Cartwright, J.C. Williams, D. Oceandy, J.M. Redondo, et al. 2005. 
The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of 
activated T-cell pathway via interaction with the calcineurin A catalytic 
subunit. J. Biol. Chem. 280:29479–29487. http://dx.doi.org/10.1074/jbc 
.M501326200
Cartwright, E.J., D. Oceandy, and L. Neyses. 2009. Physiological implica-
tions of the interaction between the plasma membrane calcium pump 
and nNOS. Pflugers Arch. 457:665–671. http://dx.doi.org/10.1007/ 
s00424-008-0455-z
Chami, M., D. Ferrari, P. Nicotera, P. Paterlini-Bréchot, and R. Rizzuto. 2003. 
Caspase-dependent alterations of Ca2+ signaling in the induction of apop-
tosis by hepatitis B virus X protein. J. Biol. Chem. 278:31745–31755. 
http://dx.doi.org/10.1074/jbc.M304202200
Chang, E.J., J. Ha, H. Huang, H.J. Kim, J.H. Woo, Y. Lee, Z.H. Lee, J.H. Kim, 
and H.H. Kim. 2008a. The JNK-dependent CaMK pathway restrains the 
reversion of committed cells during osteoclast differentiation. J. Cell Sci. 
121:2555–2564. http://dx.doi.org/10.1242/jcs.028217
Chang, E.J., J. Ha, F. Oerlemans, Y.J. Lee, S.W. Lee, J. Ryu, H.J. Kim, Y. Lee, 
H.M. Kim, J.Y. Choi, et al. 2008b. Brain-type creatine kinase has a cru-
cial role in osteoclast-mediated bone resorption. Nat. Med. 14:966–972. 
http://dx.doi.org/10.1038/nm.1860
Clapham, D.E. 2007. Calcium signaling. Cell. 131:1047–1058. http://dx.doi 
.org/10.1016/j.cell.2007.11.028
Osteoblast differentiation
Calvarial cells were isolated from 1-d-old mice as described previously (Lee 
et al., 2009). Osteoblast differentiation was induced by culturing cells in 
osteogenic medium (-MEM containing 10 mM -glycerophosphate and 
100 µg/ml ascorbic acid) for 7 d, which was confirmed by AP staining.
Cytotoxicity assay
The cytotoxicity of eosin on BMMs was assessed using CCK-8 reagents 
(Dojindo Laboratories) that produce formazan dye in the presence of live 
cells. The optical density was measured at 450 nm.
Lipopolysaccharide-induced bone resorption in vivo
Mice were injected with 5 mg/kg LPS (from Escherichia coli 0111:B4; 
Sigma-Aldrich) intraperitoneally twice with a 4-d interval as described pre-
viously (Chang et al., 2008b). 30 µl of 5 mM eosin were injected at the 
proximal ends of tibiae twice with a 4-d interval. At 7 d after the first injec-
tion, mice were killed and tibiae sections were stained for TRAP activity.
Calvarial bone resorption assay in vivo
Control or PMCA siRNA oligonucleotides (20 µM, 30 µl) were mixed with 
10 µl Lipofectamine 2000 and injected into the subcutaneous space of cal-
variae of 5-wk-old ICR mice three times with 2-d intervals. As a positive 
control for bone resorption, collagen matrices soaked with RANKL (10 µg) 
were implanted on the periosteal surface of calvariae. At 6 d after final 
siRNA injection, mice were killed and calvariae were subjected to CT or 
processed for histological analyses.
Bone histomorphometry
Bone histomorphometric analyses were performed on paraffin-embedded 
sections as described previously (Chang et al., 2008b). In brief, calvariae or 
tibiae were fixed in 4% paraformaldehyde, decalcified in 12% EDTA for 
4 wk, and embedded in paraffin. 5-µm-thick tissue sections were subjected 
to TRAP staining or hematoxylin/eosin staining according to standard proce-
dures. For the measurements of mineralized bones, tibiae were fixed in 4% 
paraformaldehyde, dehydrated in graded ethanol, and embedded in methyl 
methacrylate resin. Sections of 5 µm thickness were subjected to von Kossa’s 
silver nitrate staining followed by van Gieson’s counterstaining.
CT analysis
Femurs of 6-wk-old male Atp2b1+/, Atp2b4/, and wild-type littermate 
mice were analyzed by CT using the SkyScan 1072 system (SkyScan). 
Trabecular bone volume was measured in the 1-mm region in length, 1 mm 
below the distal growth plate of femurs. A total of 350–400 tomographic 
slices were acquired and 3D analyses were performed with CT volume 
software (ver 1.11; SkyScan).
Detection of apoptosis in vivo and in vitro by TUNEL assay
TUNEL assay using In situ Cell Death Detection kit (Roche) coupled to an 
AP-conjugated antobody was performed on bone tissue sections of 6-wk-old 
male Atp2b1+/, Atp2b4/, and wild-type littermate mice to evaluate in 
vivo osteoclast apoptosis. For the detection of in vitro osteoclast apoptosis, 
mature osteoclasts were purified from the co-cultures of mouse bone mar-
row cells and calvarial osteoblasts (Ha et al., 2004). After transferring onto 
dentine discs (Immunodiagnostic Systems), mature osteoclasts (2 × 102 
cells/disc) were transfected with PMCA siRNA oligonucleotides and further 
cultured with 30 ng/ml M-CSF and 100 ng/ml RANKL for 2 d. TUNEL assay 
with In situ Cell Death Detection kit coupled to an FITC-conjugated antibody 
was performed followed by Cy3-conjugated phalloidin (Invitrogen) and 
DAPI (Invitrogen) staining.
NO measurements
BMMs on glass coverslips were transfected with control or isoform-specific 
PMCA siRNAs and were further cultured with 30 ng/ml M-CSF and 100 ng/ml 
RANKL for 2 d. Cells were loaded with 5 µM of the cell-permeable fluores-
cent NO indicator DAF-2 DA (EMD Millipore) for 30 min. NO-dependent fluo-
rescence was observed under a laser-scanning microscope. To confirm the 
specificity of DAF-2 DA fluorescence, cells were cultured overnight with 
100 ng/ml LPS in the absence or presence of a NO synthase inhibitor, L-NMMA 
(10 µM; EMD Millipore), for 2 h before DAF-2 DA loading.
Statistical analysis
The Student’s t test was used to determine the significance of differences 
between two groups. Comparison of multiple results was performed by 
one-way analysis of variance followed by Student Knewman-Keuls post hoc 
tests. Differences with P < 0.05 were regarded as significant. The gene 








Published December 24, 2012
JCB • VOLUME 199 • NUMBER 7 • 2012 1158
Pellegrini, L., and L. Scorrano. 2007. A cut short to death: Parl and Opa1 in 
the regulation of mitochondrial morphology and apoptosis. Cell Death 
Differ. 14:1275–1284. http://dx.doi.org/10.1038/sj.cdd.4402145
Ryu, J., H.J. Kim, E.J. Chang, H. Huang, Y. Banno, and H.H. Kim. 2006. 
Sphingosine 1-phosphate as a regulator of osteoclast differentiation and 
osteoclast-osteoblast coupling. EMBO J. 25:5840–5851. http://dx.doi 
.org/10.1038/sj.emboj.7601430
Salo, J., P. Lehenkari, M. Mulari, K. Metsikkö, and H.K. Väänänen. 1997. 
Removal of osteoclast bone resorption products by transcytosis. Science. 
276:270–273. http://dx.doi.org/10.1126/science.276.5310.270
Schuh, K., S. Uldrijan, M. Telkamp, N. Rothlein, and L. Neyses. 2001. The 
plasmamembrane calmodulin-dependent calcium pump: a major regu-
lator of nitric oxide synthase I. J. Cell Biol. 155:201–205. http://dx.doi 
.org/10.1083/jcb.200104131
Schuh, K., T. Quaschning, S. Knauer, K. Hu, S. Kocak, N. Roethlein, and L. 
Neyses. 2003. Regulation of vascular tone in animals overexpressing the 
sarcolemmal calcium pump. J. Biol. Chem. 278:41246–41252. http://
dx.doi.org/10.1074/jbc.M307606200
Schuh, K., E.J. Cartwright, E. Jankevics, K. Bundschu, J. Liebermann, J.C. 
Williams, A.L. Armesilla, M. Emerson, D. Oceandy, K.P. Knobeloch, 
and L. Neyses. 2004. Plasma membrane Ca2+ ATPase 4 is required for 
sperm motility and male fertility. J. Biol. Chem. 279:28220–28226. 
http://dx.doi.org/10.1074/jbc.M312599200
Sharma, S.M., A. Bronisz, R. Hu, K. Patel, K.C. Mansky, S. Sif, and M.C. 
Ostrowski. 2007. MITF and PU.1 recruit p38 MAPK and NFATc1 to 
target genes during osteoclast differentiation. J. Biol. Chem. 282:15921–
15929. http://dx.doi.org/10.1074/jbc.M609723200
Shinohara, M., T. Koga, K. Okamoto, S. Sakaguchi, K. Arai, H. Yasuda, T. 
Takai, T. Kodama, T. Morio, R.S. Geha, et al. 2008. Tyrosine kinases Btk 
and Tec regulate osteoclast differentiation by linking RANK and ITAM 
signals. Cell. 132:794–806. http://dx.doi.org/10.1016/j.cell.2007.12.037
Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, 
M. Isobe, T. Yokochi, J. Inoue, et al. 2002. Induction and activation of 
the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in 
terminal differentiation of osteoclasts. Dev. Cell. 3:889–901. http://dx.doi 
.org/10.1016/S1534-5807(02)00369-6
van der Eerden, B.C., J.G. Hoenderop, T.J. de Vries, T. Schoenmaker, C.J. 
Buurman, A.G. Uitterlinden, H.A. Pols, R.J. Bindels, and J.P. van 
Leeuwen. 2005. The epithelial Ca2+ channel TRPV5 is essential for proper 
osteoclastic bone resorption. Proc. Natl. Acad. Sci. USA. 102:17507–
17512. http://dx.doi.org/10.1073/pnas.0505789102
Walsh, M.C., N. Kim, Y. Kadono, J. Rho, S.Y. Lee, J. Lorenzo, and Y. Choi. 
2006. Osteoimmunology: interplay between the immune system and bone 
metabolism. Annu. Rev. Immunol. 24:33–63. http://dx.doi.org/10.1146/
annurev.immunol.24.021605.090646
Yang, S., and Y.P. Li. 2007. RGS10-null mutation impairs osteoclast differentia-
tion resulting from the loss of [Ca2+]i oscillation regulation. Genes Dev. 
21:1803–1816. http://dx.doi.org/10.1101/gad.1544107
Yang, Y.M., M.S. Kim, A. Son, J.H. Hong, K.H. Kim, J.T. Seo, S.I. Lee, and 
D.M. Shin. 2009. Alteration of RANKL-induced osteoclastogenesis in 
primary cultured osteoclasts from SERCA2+/- mice. J. Bone Miner. Res. 
24:1763–1769. http://dx.doi.org/10.1359/jbmr.090420
Yoon, S.H., Y. Lee, H.J. Kim, Z.H. Lee, S.W. Hyung, S.W. Lee, and H.H. 
Kim. 2009. Lyn inhibits osteoclast differentiation by interfering with 
PLCgamma1-mediated Ca2+ signaling. FEBS Lett. 583:1164–1170. 
http://dx.doi.org/10.1016/j.febslet.2009.03.005
Di Leva, F., T. Domi, L. Fedrizzi, D. Lim, and E. Carafoli. 2008. The plasma 
membrane Ca2+ ATPase of animal cells: structure, function and regula-
tion. Arch. Biochem. Biophys. 476:65–74. http://dx.doi.org/10.1016/ 
j.abb.2008.02.026
Gatto, C., and M.A. Milanick. 1993. Inhibition of the red blood cell cal-
cium pump by eosin and other fluorescein analogues. Am. J. Physiol. 
264:C1577–C1586.
Gatto, C., C.C. Hale, W. Xu, and M.A. Milanick. 1995. Eosin, a potent inhibitor 
of the plasma membrane Ca pump, does not inhibit the cardiac Na-Ca ex-
changer. Biochemistry. 34:965–972. http://dx.doi.org/10.1021/bi00003a031
Ha, H., H.B. Kwak, S.W. Lee, H.M. Jin, H.M. Kim, H.H. Kim, and Z.H. Lee. 2004. 
Reactive oxygen species mediate RANK signaling in osteoclasts. Exp. 
Cell Res. 301:119–127. http://dx.doi.org/10.1016/j.yexcr.2004.07.035
Ha, J., H.S. Choi, Y. Lee, H.J. Kwon, Y.W. Song, and H.H. Kim. 2010. CXC 
chemokine ligand 2 induced by receptor activator of NF-kappa B ligand 
enhances osteoclastogenesis. J. Immunol. 184:4717–4724. http://dx.doi 
.org/10.4049/jimmunol.0902444
Kaneda, T., T. Nojima, M. Nakagawa, A. Ogasawara, H. Kaneko, T. Sato, H. 
Mano, M. Kumegawa, and Y. Hakeda. 2000. Endogenous production of 
TGF-beta is essential for osteoclastogenesis induced by a combination of 
receptor activator of NF-kappa B ligand and macrophage-colony-stimulating 
factor. J. Immunol. 165:4254–4263.
Kim, H.J., Y. Lee, E.J. Chang, H.M. Kim, S.P. Hong, Z.H. Lee, J. Ryu, and 
H.H. Kim. 2007. Suppression of osteoclastogenesis by N,N-dimethyl-D-
erythro-sphingosine: a sphingosine kinase inhibition-independent action. 
Mol. Pharmacol. 72:418–428. http://dx.doi.org/10.1124/mol.107.034173
Kim, K., J.H. Kim, J. Lee, H.M. Jin, S.H. Lee, D.E. Fisher, H. Kook, K.K. 
Kim, Y. Choi, and N. Kim. 2005. Nuclear factor of activated T cells c1 
induces osteoclast-associated receptor gene expression during tumor 
necrosis factor-related activation-induced cytokine-mediated osteoclas-
togenesis. J. Biol. Chem. 280:35209–35216. http://dx.doi.org/10.1074/
jbc.M505815200
Kuroda, Y., C. Hisatsune, T. Nakamura, K. Matsuo, and K. Mikoshiba. 2008. 
Osteoblasts induce Ca2+ oscillation-independent NFATc1 activation 
during osteoclastogenesis. Proc. Natl. Acad. Sci. USA. 105:8643–8648. 
http://dx.doi.org/10.1073/pnas.0800642105
Lee, Y., S.W. Hyung, H.J. Jung, H.J. Kim, J. Staerk, S.N. Constantinescu, E.J. 
Chang, Z.H. Lee, S.W. Lee, and H.H. Kim. 2008. The ubiquitin-mediated 
degradation of Jak1 modulates osteoclastogenesis by limiting interferon-
beta-induced inhibitory signaling. Blood. 111:885–893. http://dx.doi 
.org/10.1182/blood-2007-03-082941
Lee, Y., J. Ha, H.J. Kim, Y.S. Kim, E.J. Chang, W.J. Song, and H.H. Kim. 2009. 
Negative feedback Inhibition of NFATc1 by DYRK1A regulates bone 
homeostasis. J. Biol. Chem. 284:33343–33351. http://dx.doi.org/10.1074/
jbc.M109.042234
Lee, Y., H.J. Kim, C.K. Park, W.S. Kim, Z.H. Lee, and H.H. Kim. 2012. Novel 
extraneural role of neurite outgrowth inhibitor A: modulation of osteoclas-
togenesis via positive feedback regulation of nuclear factor of activated 
T cell cytoplasmic 1. J. Bone Miner. Res. 27:1043–1054. http://dx.doi 
.org/10.1002/jbmr.1561
Li, J.P., H. Kajiya, F. Okamoto, A. Nakao, T. Iwamoto, and K. Okabe. 2007. Three 
Na+/Ca2+ exchanger (NCX) variants are expressed in mouse osteoclasts 
and mediate calcium transport during bone resorption. Endocrinology. 
148:2116–2125. http://dx.doi.org/10.1210/en.2006-1321
Lorget, F., S. Kamel, R. Mentaverri, A. Wattel, M. Naassila, M. Maamer, and M. 
Brazier. 2000. High extracellular calcium concentrations directly stimu-
late osteoclast apoptosis. Biochem. Biophys. Res. Commun. 268:899–903. 
http://dx.doi.org/10.1006/bbrc.2000.2229
Moonga, B.S., R. Davidson, L. Sun, O.A. Adebanjo, J. Moser, M. Abedin, N. 
Zaidi, C.L. Huang, and M. Zaidi. 2001. Identification and characteriza-
tion of a sodium/calcium exchanger, NCX-1, in osteoclasts and its role in 
bone resorption. Biochem. Biophys. Res. Commun. 283:770–775. http://
dx.doi.org/10.1006/bbrc.2001.4870
Moonga, B.S., S. Li, J. Iqbal, R. Davidson, V.S. Shankar, P.J. Bevis, A. Inzerillo, 
E. Abe, C.L. Huang, and M. Zaidi. 2002. Ca(2+) influx through the 
osteoclastic plasma membrane ryanodine receptor. Am. J. Physiol. Renal 
Physiol. 282:F921–F932.
Nilforoushan, D., A. Gramoun, M. Glogauer, and M.F. Manolson. 2009. Nitric 
oxide enhances osteoclastogenesis possibly by mediating cell fusion. 
Nitric Oxide. 21:27–36. http://dx.doi.org/10.1016/j.niox.2009.04.002
Nowycky, M.C., and A.P. Thomas. 2002. Intracellular calcium signaling. J. Cell 
Sci. 115:3715–3716. http://dx.doi.org/10.1242/jcs.00078
Okunade, G.W., M.L. Miller, G.J. Pyne, R.L. Sutliff, K.T. O’Connor, J.C. 
Neumann, A. Andringa, D.A. Miller, V. Prasad, T. Doetschman, et al. 
2004. Targeted ablation of plasma membrane Ca2+-ATPase (PMCA) 1 and 
4 indicates a major housekeeping function for PMCA1 and a critical role 









Published December 24, 2012
